Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews.

Authors:
Pelletier R; Ng K; Alkabbani W; Labib Y; Mourad N and 1 more

Journal:
Ther Adv Drug Saf

Publication Year: 2021

DOI:
10.1177/2042098621989134

PMCID:
PMC7844442

PMID:
33552467

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Drug Saf

Abbreviation: Ther Adv Drug Saf

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass in…
Shaikh F; Wynne R; L Castelino R and 3 more (2024) - Transparency Score: 3/6
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Eve…
Jiang T; Su H; Xu J and 9 more (2024) - Transparency Score: 3/6
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition betwe…
Sørensen CA; Jeffery L; Roelsgaard K and 4 more (2023) - Transparency Score: 3/6
Analysis of the nature and contributory factors of medication safety incidents following hospital d…
Alqenae FA; Steinke D; Carson-Stevens A and 1 more (2023) - Transparency Score: 3/6
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance u…
Altebainawi AF; Alfaraj LA; Alharbi AA and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."

Evidence found in paper:

"The protocol for this study is registered with the PROSPERO international prospective register of systematic reviews (PROSPERO 2019: CRD42019135863)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025